Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid Tumors
Clinical trial NCT03901950 · COMPLETED
Trial details
- NCT number
- NCT03901950
- Sponsor
- Evopoint Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2021-12-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.